GENFIT Announces First Half-Year 2024 Financial Results with a Corporate Update
Sep 20, 2024
Biopharmaceutical Invest Information
Bolt Biotherapeutics Welcomes Jakob Dupont, M.D., to its Board of Directors
Sep 5, 2024
Cingulate Inc. Engages In the Benzinga All Live Access Event
Aug 28, 2024
Kent Kresa Concludes Tenure on MannKind Board; Steven Binder Set to Join
Aug 15, 2024
SpringWorks Therapeutics Schedules Q2 2024 Earnings Call for August 7
Jul 24, 2024
Rosen Law Firm Investigates Claims Against Biomea Fusion, Inc. on Behalf of Shareholders
Jun 17, 2024
Belite Bio Awarded Sakigake Designation for Its Potential Therapeutic Tinlarebant in Stargardt Disease Treatment
Jun 13, 2024
FDA Grants Accelerated Approval to Ipsen and Genfit's Iqirvo for Liver Disease Treatment
Jun 12, 2024
GENFIT Reaches Historic FDA Approval with Ipsen's Iqirvo® for Primary Biliary Cholangitis
Jun 11, 2024
Silo Pharma Initiates $2 Million Registered Direct Offering
Jun 5, 2024
Ventyx Biosciences to Engage Investors at Trio of Conferences
May 17, 2024
Ventyx Biosciences Shareholders with Losses Encouraged to Contact The Gross Law Firm for Class Action Inquiry - VTYX
Mar 21, 2024
Liquidia Technologies, Inc. (LQDA) Reports Q4 Financial Disappointment, Misses Revenue Forecasts
Mar 13, 2024
Cytokinetics Announces Participation in Upcoming March Investor Conferences
Mar 5, 2024
Arcutis Biotherapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Feb 29, 2024
Ardelyx Inc. Receives Downgrade to Sell by StockNews.com
Feb 27, 2024
Cytokinetics Set to Reveal Q4 Financial Results on February 27, 2024
Feb 14, 2024
Navigating the Futures Market Heat: Spotlight on 5 Stocks Ready for Action
Feb 12, 2024
Anavex Life Sciences Secures U.S. Patent for Blarcamesine in Neurodevelopmental Disorder Treatment
Jan 9, 2024
SpringWorks Therapeutics Announces Presentation at J.P. Morgan Healthcare Conference
Dec 21, 2023
Setback for Mirum Pharmaceuticals as Livmarli Fails in Mid-Stage Study for Biliary Atresia
Dec 20, 2023
GENFIT Foresees Growth with Elafibranor Approvals for PBC Across US and Europe
Dec 9, 2023
Abeona Therapeutics Receives Sell Rating Amidst Stock Performance Scrutiny
Nov 15, 2023
atai Life Sciences Reports Q3 Earnings and Financial Health
Nov 14, 2023
StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX)
Nov 13, 2023
StockNews.com Issues a Sell Rating for Minerva Neurosciences Amid Institutional Trading Activity
Nov 12, 2023
TG Therapeutics TGTX Upgraded to 'Buy' by StockNews.com Amid Positive Analyst Sentiment
Nov 12, 2023
Sangamo Therapeutics (NASDAQ:SGMO) Receives New Coverage From StockNews.com Amid Financial Analysis From Significant Players
Nov 12, 2023
Xencor Receives Upgrade by StockNews.com to Hold Status Amid Analyst Reviews
Nov 12, 2023
Intellia Therapeutics Surpasses Q3 Earnings Expectations and Announces Progress in Gene-Editing Pipeline
Nov 11, 2023
Immunovant Surpasses Q2 Earnings Expectations with a Strong Focus on Future Pipeline
Nov 10, 2023
GENFIT Announces Q3 2023 Financial Results with Cash Reserves and Revenue Insights
Nov 10, 2023
Ventyx Biosciences Shows Turnaround Signs Amid Oversold Conditions
Nov 10, 2023
Ventyx Biosciences, Inc. (VTYX) Anticipates Reversal After a Significant Drop
Nov 10, 2023
GH Research Advances Clinical Trials for GH001 in the Fight Against Treatment-Resistant Depression
Nov 9, 2023
GH Research Announces Clinical Progress and Path Forward for GH001 in the Battle Against Treatment-Resistant Depression
Nov 9, 2023
GH Research Advances Clinical Development for GH001 in Treatment-Resistant Depression
Nov 9, 2023